Skip to main content
OpenTrials

Clinical trial condition

Urticaria

Explore clinical trials studying Urticaria. Study availability and eligibility vary by location and protocol.

320 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Urticaria trial results

Completed

A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) (LIBERTY-CSU CUPIDKids)

NCT05526521

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Pediatric Dermatology of Miami Site Number : 8400015 Coral Gables, Florida, United States
  • Treasure Valley Medical Research Site Number : 8400019 Boise, Idaho, United States
  • Washington University School of Medicine- Site Number : 8400004 St Louis, Missouri, United States
  • Boston Childrens Health Physicians Site Number : 8400017 Hawthorne, New York, United States
View all 15 locations
View Trial Details
Completed

Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

NCT06343779

Conditions
Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +27 more
Locations
  • Study Site Birmingham, Alabama, United States
  • Study Site Paradise Valley, Arizona, United States
  • Study Site Little Rock, Arkansas, United States
  • Study Site San Diego, California, United States
View all 76 locations
View Trial Details
Completed

A Study of CDX-0159 in Patients With Chronic Inducible Urticaria

NCT05405660

Conditions
Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +10 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Allervie Clinical Research Montgomery, Alabama, United States
  • One of a Kind Clinical Research Center, LLC Paradise Valley, Arizona, United States
  • Little Rock Allergy & Asthma CRC Little Rock, Arkansas, United States
View all 76 locations
View Trial Details
Completed

A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks.

NCT05795153

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Acuro Research Inc Little Rock, Arkansas, United States
  • Florida Ctr Allergy Asthma Research Aventura, Florida, United States
  • Finlay Medical Research Greenacres City, Florida, United States
  • Treasure Valley Medical Research Boise, Idaho, United States
View all 44 locations
View Trial Details
Completed

Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)

NCT04681729

Conditions
Cold Urticaria, Hypersensitivity, Hypersensitivity, Immediate, +5 more
Locations
  • Allergy and Asthma Medical Group and Research Center-Site Number:8400001 San Diego, California, United States
  • Treasure Valley Medical Research-Site Number:8400007 Boise, Idaho, United States
  • Allergy & Asthma Specialists, PSC-Site Number:8400003 Owensboro, Kentucky, United States
  • Johns Hopkins University (Asthma and Allergy Center)-Site Number:8400005 Baltimore, Maryland, United States
View all 33 locations
View Trial Details
Completed

A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II

NCT04130191

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Medical University of Vienna Vienna, Austria
  • Klinikum der Johann-Wolfgang Goethe-Universitat Frankfurt am Main, Hesse, Germany
  • Charité - Universitätsmedizin Berlin Berlin, Germany
  • Universitatsklinikum Dusseldorf Düsseldorf, Germany
View all 19 locations
View Trial Details

Related conditions